A rare point mutation in the Ras oncogene in hepatocellular carcinoma

Akinobu Taketomi, Ken Shirabe, Jun Muto, Shohei Yoshiya, Takashi Motomura, Yohei Mano, Toru Ikegami, Tomoharu Yoshizumi, Kenji Sugio, Yoshihiko Maehara

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: The Ras gene is one of the oncogenes most frequently detected in human cancers, and codes for three proteins (K-, N-, and H-Ras). The aim of this study was to examine the mutations in codons 12, 13 and 61 of the three Ras genes in cases of human hepatocellular carcinoma (HCC). Methods: Paired samples of HCC and corresponding non-malignant liver tissue were collected from 61 patients who underwent hepatectomy. A dot-blot analysis was used to analyze the products of the polymerase chain reaction (PCR) amplification of codons 12, 13, and 61 of K-, N- and H-Ras for mutations. Results: Only one mutation (K-Ras codon 13; Gly to Asp) was detected among the 61 patients. Interestingly, this patient had a medical history of surgery for both gastric cancer and right lung cancer. No mutations were found in codons 12 and 61 of K-Ras or codons 12, 13 and 61 of the N-Ras and H-Ras genes in any of the HCCs or corresponding non-malignant tissues. Conclusions: These findings indicated that the activation of Ras proto-oncogenes by mutations in codons 12, 13, and 61 does not play a major role in hepatocellular carcinogenesis.

Original languageEnglish
Pages (from-to)289-292
Number of pages4
JournalSurgery Today
Volume43
Issue number3
DOIs
Publication statusPublished - Mar 1 2013

Fingerprint

ras Genes
Point Mutation
Codon
Hepatocellular Carcinoma
Mutation
Lung Neoplasms
Proto-Oncogenes
Hepatectomy
Oncogenes
Stomach Neoplasms
Carcinogenesis
Polymerase Chain Reaction
Liver
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Taketomi, A., Shirabe, K., Muto, J., Yoshiya, S., Motomura, T., Mano, Y., ... Maehara, Y. (2013). A rare point mutation in the Ras oncogene in hepatocellular carcinoma. Surgery Today, 43(3), 289-292. https://doi.org/10.1007/s00595-012-0462-8

A rare point mutation in the Ras oncogene in hepatocellular carcinoma. / Taketomi, Akinobu; Shirabe, Ken; Muto, Jun; Yoshiya, Shohei; Motomura, Takashi; Mano, Yohei; Ikegami, Toru; Yoshizumi, Tomoharu; Sugio, Kenji; Maehara, Yoshihiko.

In: Surgery Today, Vol. 43, No. 3, 01.03.2013, p. 289-292.

Research output: Contribution to journalArticle

Taketomi, A, Shirabe, K, Muto, J, Yoshiya, S, Motomura, T, Mano, Y, Ikegami, T, Yoshizumi, T, Sugio, K & Maehara, Y 2013, 'A rare point mutation in the Ras oncogene in hepatocellular carcinoma', Surgery Today, vol. 43, no. 3, pp. 289-292. https://doi.org/10.1007/s00595-012-0462-8
Taketomi A, Shirabe K, Muto J, Yoshiya S, Motomura T, Mano Y et al. A rare point mutation in the Ras oncogene in hepatocellular carcinoma. Surgery Today. 2013 Mar 1;43(3):289-292. https://doi.org/10.1007/s00595-012-0462-8
Taketomi, Akinobu ; Shirabe, Ken ; Muto, Jun ; Yoshiya, Shohei ; Motomura, Takashi ; Mano, Yohei ; Ikegami, Toru ; Yoshizumi, Tomoharu ; Sugio, Kenji ; Maehara, Yoshihiko. / A rare point mutation in the Ras oncogene in hepatocellular carcinoma. In: Surgery Today. 2013 ; Vol. 43, No. 3. pp. 289-292.
@article{794fd7e4ba7147f390f5ab751965b6ec,
title = "A rare point mutation in the Ras oncogene in hepatocellular carcinoma",
abstract = "Purpose: The Ras gene is one of the oncogenes most frequently detected in human cancers, and codes for three proteins (K-, N-, and H-Ras). The aim of this study was to examine the mutations in codons 12, 13 and 61 of the three Ras genes in cases of human hepatocellular carcinoma (HCC). Methods: Paired samples of HCC and corresponding non-malignant liver tissue were collected from 61 patients who underwent hepatectomy. A dot-blot analysis was used to analyze the products of the polymerase chain reaction (PCR) amplification of codons 12, 13, and 61 of K-, N- and H-Ras for mutations. Results: Only one mutation (K-Ras codon 13; Gly to Asp) was detected among the 61 patients. Interestingly, this patient had a medical history of surgery for both gastric cancer and right lung cancer. No mutations were found in codons 12 and 61 of K-Ras or codons 12, 13 and 61 of the N-Ras and H-Ras genes in any of the HCCs or corresponding non-malignant tissues. Conclusions: These findings indicated that the activation of Ras proto-oncogenes by mutations in codons 12, 13, and 61 does not play a major role in hepatocellular carcinogenesis.",
author = "Akinobu Taketomi and Ken Shirabe and Jun Muto and Shohei Yoshiya and Takashi Motomura and Yohei Mano and Toru Ikegami and Tomoharu Yoshizumi and Kenji Sugio and Yoshihiko Maehara",
year = "2013",
month = "3",
day = "1",
doi = "10.1007/s00595-012-0462-8",
language = "English",
volume = "43",
pages = "289--292",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - A rare point mutation in the Ras oncogene in hepatocellular carcinoma

AU - Taketomi, Akinobu

AU - Shirabe, Ken

AU - Muto, Jun

AU - Yoshiya, Shohei

AU - Motomura, Takashi

AU - Mano, Yohei

AU - Ikegami, Toru

AU - Yoshizumi, Tomoharu

AU - Sugio, Kenji

AU - Maehara, Yoshihiko

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Purpose: The Ras gene is one of the oncogenes most frequently detected in human cancers, and codes for three proteins (K-, N-, and H-Ras). The aim of this study was to examine the mutations in codons 12, 13 and 61 of the three Ras genes in cases of human hepatocellular carcinoma (HCC). Methods: Paired samples of HCC and corresponding non-malignant liver tissue were collected from 61 patients who underwent hepatectomy. A dot-blot analysis was used to analyze the products of the polymerase chain reaction (PCR) amplification of codons 12, 13, and 61 of K-, N- and H-Ras for mutations. Results: Only one mutation (K-Ras codon 13; Gly to Asp) was detected among the 61 patients. Interestingly, this patient had a medical history of surgery for both gastric cancer and right lung cancer. No mutations were found in codons 12 and 61 of K-Ras or codons 12, 13 and 61 of the N-Ras and H-Ras genes in any of the HCCs or corresponding non-malignant tissues. Conclusions: These findings indicated that the activation of Ras proto-oncogenes by mutations in codons 12, 13, and 61 does not play a major role in hepatocellular carcinogenesis.

AB - Purpose: The Ras gene is one of the oncogenes most frequently detected in human cancers, and codes for three proteins (K-, N-, and H-Ras). The aim of this study was to examine the mutations in codons 12, 13 and 61 of the three Ras genes in cases of human hepatocellular carcinoma (HCC). Methods: Paired samples of HCC and corresponding non-malignant liver tissue were collected from 61 patients who underwent hepatectomy. A dot-blot analysis was used to analyze the products of the polymerase chain reaction (PCR) amplification of codons 12, 13, and 61 of K-, N- and H-Ras for mutations. Results: Only one mutation (K-Ras codon 13; Gly to Asp) was detected among the 61 patients. Interestingly, this patient had a medical history of surgery for both gastric cancer and right lung cancer. No mutations were found in codons 12 and 61 of K-Ras or codons 12, 13 and 61 of the N-Ras and H-Ras genes in any of the HCCs or corresponding non-malignant tissues. Conclusions: These findings indicated that the activation of Ras proto-oncogenes by mutations in codons 12, 13, and 61 does not play a major role in hepatocellular carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84878483955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878483955&partnerID=8YFLogxK

U2 - 10.1007/s00595-012-0462-8

DO - 10.1007/s00595-012-0462-8

M3 - Article

VL - 43

SP - 289

EP - 292

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 3

ER -